Project cooperationUpdated on 16 January 2026
Partner Search: 3D Organoid Expertise for High-Fidelity GBM Device Validation
Strategy & Research Associate at Migration Biotherapeutics
Cambridge, United Kingdom
About
Migration Biotherapeutics is developing the ALIGHT device, an innovative "ecological trap" designed to manage refractory glioblastoma by exploiting natural cell migratory instincts via aligned electrospun nanofibers.
Under the HORIZON-MISS-2026-02-CANCER-03 call, we are seeking research organisations specialising in high-fidelity 3D cancer organoid models and the replication of the tumour microenvironment. We seek to enhance the in vitro validation of our non-pharmacological device by testing its performance in complex 3D models that accurately mimic the human brain. This partnership is vital to establishing definitive proof-of-concept evidence. Migration Bio offers a unique industrial-academic bridge.
Stage
- Design - setting the project scope
- Completing the consortia
Topic
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Type
- Consortium/Coordinator seeks Partners
- Offering Expertise to Consortias
Organisation
Similar opportunities
Project cooperation
Seeking In Silico Modelling for Nanofiber-Based Cancer "Ecological Traps"
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- Consortium/Coordinator seeks Partners
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
Enoch Alex
Strategy & Research Associate at Migration Biotherapeutics
Cambridge, United Kingdom
Project cooperation
- Offering Expertise to Consortias
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Javier Carmona
Head of Scientific Strategy at Vall d'Hebron Institute of Oncology
BARCELONA, Spain
Project cooperation
Extracellular vesicles analysis for cancer diagnostics and pathology
- Offering Expertise to Consortias
- Ideation - identifying the project idea
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Masoud Darabi Amin
Group leader at University Hospital Schleswig-Holstein (UKSH)
Lübeck, Germany